Status:
RECRUITING
INtensity of OVarian Stimualtion and Euploid Embryos
Lead Sponsor:
Fundación Santiago Dexeus Font
Conditions:
Fertility
Eligibility:
FEMALE
38-42 years
Phase:
PHASE4
Brief Summary
This randomized trial was designed as a no-inferiority trial aiming to evaluate if the intensity of stimulation (a milder vs a more intense approach) may have an impact on the number of euploid embryo...
Eligibility Criteria
Inclusion
- Infertile patients with indication for IVF
- Undergoing preimplantation genetic screening cycles
- AMH \>= 1.5 ng/ml and \< 3.5 ng/ml (AMH result of up to one year will be valid)
- BMI 18.5 - 30 Kg/m2
Exclusion
- Severe male factor requiring TESE (testicular sperm extraction)
- AMH \< 1.5 ng/ml or \>= 3.5 ng/ml
- Administration of any other drug potentially interfering with the treatment
- Contraindication for hormonal treatment
- Recent history of severe disease requiring regular treatment (clinically significant concurrent medical condition that could compromise subject safety or interfered with the trial assessment).
- Monogenic disease to be detected with PGT-M
Key Trial Info
Start Date :
December 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06154083
Start Date
December 12 2023
End Date
May 15 2026
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Quiron Dexeus
Barcelona, Spain, 08028